secwatch.observer — SEC 8-K summary
======================================

Issuer:     Transcode Therapeutics, Inc. (RNAZ)
CIK:        0001829635
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0001104659-25-016947
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransCode shareholders approve warrant adjustments and share issuance at special meeting
--------------------------------------------------------------------------------

- Proposal One approved: full issuance of shares upon exercise of Series C and D warrants with floor price of $2.4882.
- Proposal Two approved: adjournment if needed to solicit more votes; not used as Proposal One passed.
- Vote on Proposal One: 130,226 for, 51,288 against, 8,722 abstained; 190,236 shares present (quorum).
- Total shares entitled to vote: 523,261; no broker non-votes on either proposal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829635/000110465925016947/0001104659-25-016947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829635/000110465925016947/tm257516d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-016947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer